Saito, Keigo
Takahata, Takenori
Nakagawa, Junichi
Chen, Yu
Saito, Kensuke
Kamata, Kosuke
Tachita, Takuto
Yamashita, Satoru
Ueno, Kayo
Sato, Atsushi
Sakuraba, Hirotake
Niioka, Takenori https://orcid.org/0000-0002-4560-6423
Article History
Accepted: 5 March 2025
First Online: 4 April 2025
Declarations
:
: The authors declare that they have no conflicts of interest.
: The authors did not receive support from any organization for the work reported in this manuscript.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: All procedures performed in studies involving human participants were carried out in accordance with the ethical standards of the Ethics Committee of Hirosaki University Graduate School of Medicine (project identification code: 2018-055-4) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in this study.
: Informed consent for publication was obtained from all participants.
: Not applicable.
: Conceptualization: TN; investigation: TT, YC, KS, KK, TT, and SY; measurement of anticancer drugs: JN, KU, and KS; formal analysis: KS; writing—original draft preparation: KS; writing—review and editing: AS, HS, and TN. All authors read and approved the final manuscript.